Stentys (France) a clinical-stage medical device company focused on stents designed for treatment of acute myocardial infarction and coronary artery bifurcations, closed a $4.2M Series B financing bringing the round total to $22.2M. Participants include Crédit Agricole Private Equity, Sofinnova Partners and Scottish Equity Partners.